Sign Up Today and Learn More About Pillar Biosciences Stock
Invest in or calculate the value of your shares in Pillar Biosciences or other pre-IPO companies through EquityZen's platform.
Pillar Biosciences Stock (PIBO)
Pillar Biosciences specializes in sequencing technology platform and proprietary data analysis toolkit.
About Pillar Biosciences Stock
Founded
2014
Headquarters
Natick, MA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Pillar Biosciences is prized with its patent-pending targeted sequencing technology platform and a proprietary data analysis toolkit, which achieves high sensitivity and specificity with clinical samples. The platform provides a fast, simple and affordable targeted sequencing method for NGS-based oncology testing. The start-up has also released its beta version of Lung & Colon Cancer Somatic Mutation Panel and BRCA1 & BRCA2 Germline Mutation Panel to cancer centers and clinical testing companies in the US and China for validation studies. The company was founded in 2014 and is headquartered in Natick, Massachusetts.
Pillar Biosciences Press Mentions
Stay in the know about the latest news on Pillar Biosciences
Pillar Biosciences to Present Impactful Research Data at 2024 Association for Molecular Pathology (AMP) Annual Meeting
prnewswire • Nov 15, 2024
Pillar Biosciences, AstraZeneca Partner on Liquid Biopsy Testing in Europe
genomeweb • Sep 18, 2024
Pillar Biosciences Launches oncoReveal™ Nexus To Help Accelerate the Delivery of Targeted Therapy
prnewswire • Aug 27, 2024
Pillar Biosciences Incorporated’s Post
linkedin • Aug 05, 2024
Pillar Biosciences Incorporated’s Post
linkedin • Aug 05, 2024
Pillar Biosciences Management
Leadership team at Pillar Biosciences
Founder & CEO
Gang Song
Co-Founder and Chief Science Officer
Zhaohui Wang
Join now and verify your accreditation status to gain access to:
- Pillar Biosciences current valuation
- Pillar Biosciences stock price
- Available deals in Pillar Biosciences and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Pillar Biosciences stock?
Accredited investors can buy pre-IPO stock in companies like Pillar Biosciences through EquityZen funds. These investments are made available by existing Pillar Biosciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Pillar Biosciences stock?
Shareholders can sell their Pillar Biosciences stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
